A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1997
12/10/1997	EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library
12/10/1997	EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997	EP0811075A1 A method for the isolation and purification of lipid cell-wall components
12/10/1997	EP0811073A2 Methods and compositions for administering gene therapy vectors
12/10/1997	EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
12/10/1997	EP0811065A1 Antagonists of interleukin-15
12/10/1997	EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
12/10/1997	EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997	EP0811057A1 Viral preparations, vectors, immunogens, and vaccines
12/10/1997	EP0811016A1 Synthetic peptide based immunogens for the treatment of allergy
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
12/10/1997	EP0810875A1 Multifunctional enzyme
12/10/1997	EP0810873A1 Antiviral combinations of bch-189 and ritonavir
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/10/1997	EP0674625B1 Amino-substituted pyrazoles having crf antagonistic activity
12/10/1997	CN1167481A Synthetic polyunsaturated fatty acid analogues
12/10/1997	CN1167442A Composition for prevention and treatment of HIV-1 infection comprising at least two different HIV-1 reverse transcriptase inhibitors
12/10/1997	CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer
12/10/1997	CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
12/09/1997	US5696141 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/09/1997	US5696128 Adjustment prolactin profile
12/09/1997	US5696123 Neurokinin antagonists
12/09/1997	US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation
12/09/1997	US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997	US5695953 DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695768 Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
12/09/1997	US5695759 An immunoadsorbent comprising a biocompatible solid support having atleast one identified carbohydrate xenoantigen to preformed antibodies attached thereto through biocompatible linker
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/09/1997	US5695753 Transglutaminases as immunosuppressants
12/09/1997	CA1339573C Pyrimido¬4,5-d\| pyrimidine derivatives for use as bronchodilators
12/04/1997	WO1997045746A2 Prion protein binding proteins and uses thereof
12/04/1997	WO1997045735A1 Method for monitoring t-cell reactivity
12/04/1997	WO1997045448A1 An interleukin-5 antagonist
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045428A1 Novel pyridazine compounds
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045407A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997	WO1997045144A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	WO1997045140A1 Concentrated antibody preparation
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997039749A3 Method for the prevention and treatment of cachexia and anorexia
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	CA2256693A1 Method for monitoring t-cell reactivity
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256577A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256368A1 An interleukin-5 antagonist
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2256312A1 Prion protein binding proteins and uses thereof
12/04/1997	CA2254983A1 Concentrated antibody preparation
12/04/1997	CA2252747A1 Novel pyridazine compounds
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809492A1 Il-8 receptor antagonists
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0597852B1 Swine pneumonia vaccine and method for the preparation thereof
12/03/1997	CN1166834A Benzopyram and benzo-fused compounds, their preparation and their use as leukotriene B4'(LTB4) antagonists
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166785A Pharmaceutical control of inflammation
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1036591C Carbamates of repamycin
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997	US5693858 Organic salts of N,N'-diacetyl cystine
12/02/1997	US5693857 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
12/02/1997	US5693844 2-cyano-3-hydroxy-propenamides
12/02/1997	US5693803 Epoxide intermediates formed by reacting amine nucleophile with activated glycidyl derivative
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693760 Specific amino acid sequence consisting of position 2-135 includes a glycosylation site within position 96-98, binds beta-glalactoside containing moieties independent of absence of presence of calcium ions, stimulates hemagglutination
12/02/1997	US5693652 Benzimidazoles for ischemic heart conditions
12/02/1997	US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693325 Peptide vaccines and methods relating thereto
11/1997
11/27/1997	WO1997044455A1 Hematopoietic cytokine receptor
11/27/1997	WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044337A1 Benzofuran carboxamides and their therapeutic use
11/27/1997	WO1997044306A1 Chalcone derivatives and drugs containing the same

1 ... 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 ... 1172